Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
Phase 2 Unknown
34 enrolled
SG-AAA-II-01
Phase 2 Unknown
25 enrolled
Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study
Phase 1 Unknown
36 enrolled
CRCSTNPC
Phase NA Unknown
87,600 enrolled
Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma
Phase 3 Unknown
384 enrolled
Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy
Phase 2 Unknown
48 enrolled
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
Phase 2 Unknown
25 enrolled
To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer
Phase 1/2 Unknown
90 enrolled
Cell-free Tumor DNA in Head and Neck Cancer Patients
Phase NA Unknown
500 enrolled
Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions
Phase 2 Unknown
64 enrolled
DC-CIK
Phase 2 Unknown
686 enrolled
Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
Phase NA Unknown
386 enrolled
Applying PET/MR in Oncology - a Prospective Project
Phase NA Unknown
500 enrolled
Testing Accountability in Patient Adherence
Unknown
225 enrolled
A Trial of Endostar in Patients With Carcinoma of the Head and Neck
Phase 2 Unknown
24 enrolled
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
Phase 2 Unknown
40 enrolled
NKEXPHNC
Phase 1/2 Unknown
31 enrolled
Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma
Unknown
720 enrolled
Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 1 Unknown
55 enrolled
A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Phase 2 Unknown
360 enrolled
Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma
Unknown
90 enrolled
A Study of Nasopharyngeal Carcinoma From Guangdong
Unknown
2,000 enrolled
Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma
Phase NA Unknown
320 enrolled
A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
Phase 1/2 Unknown
20 enrolled
Efficacy and Safety of FORRADĀ® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Phase 2 Unknown
90 enrolled
Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRADĀ®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Phase 2 Unknown
136 enrolled
Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma
Phase 2 Unknown
80 enrolled
Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
Phase 3 Unknown
480 enrolled
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
Phase 3 Unknown
ABX-DDP-Dose
Phase 1/2 Unknown
69 enrolled
A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer
Unknown
500 enrolled
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography
Phase 2 Unknown
40 enrolled
Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
Phase 1/2 Unknown
40 enrolled
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
Phase 1/2 Unknown
46 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
Phase 1 Unknown
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
Phase NA Unknown
500 enrolled
Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Phase NA Unknown
798 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis
Phase 2 Unknown
160 enrolled
Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer
Phase 2/3 Unknown
60 enrolled
Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
Phase 2 Unknown
51 enrolled
Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
Phase 2 Unknown
42 enrolled
Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
Phase NA Unknown
340 enrolled
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
Phase 2 Unknown
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Phase 2 Unknown
60 enrolled
Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients
Unknown
50 enrolled